30 Years of Evidence
Join the experts’ corner
Featured Content
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy via Helical TomoTherapy versus Conventional Radiotherapy Combined with Concurrent Chemotherapy for Patients with Unresectable
Stage III NSCLC
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
Stereotactic Partial Breast Irradiation: 4-year Clinical Results and Cosmetic Outcomes
Norbert Meszaro et al. | Abstract 727 | ESTRO | 2024
Outcomes of Stereotactic Body Radiotherapy on Oligometastatic and Oligoprogressive Breast Cancer
Shreya Armstrong et al. | Abstract 560 | ESTRO | 2024
Evaluating Image Quality Improvement in kVCT Through Radixact TDC Upgrade for Adaptive Radiotherapy
Pak Hang Nam et al. | Abstract 1775 | ESTRO | 2024
Toxicity and Risk of Induced Second Cancer in the Treatment of Prostate Cancer using VMAT and 3D-CRT
Cheikh Tayeb et al. | Abstract 2094 | ESTRO | 2024
Surface Guided Ring Gantry Radiotherapy in Deep Inspiration Breath Hold for Breast Cancer Patients
Mustafa Kadhim et al. | Abstract 1233 | ESTRO | 2024
Clinical Introduction of a Real-time MLC-tracking System for Lung and Prostate Motion
André Haraldsson et al. | Abstract 1200 | ESTRO | 2024
Impact of VOLO Ultra Optimizer for Radixact System on Treatment Plan Quality and Efficiency
Patrizia Urso et al. | Abstract 1353 | ESTRO | 2024
Challenges in the Treatment of Pediatric Patients Undergoing Total Body Irradiation
Usha R Abraham et al. | Abstract 3032 | ESTRO | 2024
Toxicities and Outcomes of Helical TomoTherapy Craniospinal Irradiation in Primary Brain Tumours
Anne Laprie et al. | Abstract 1595 | ESTRO | 2024
Stereotactic Radiotherapy and Radiosurgery vs Fractionated Radiotherapy for Head and Neck Paragangliomas
Laura Giannini et al. | Abstract 1847 | ESTRO | 2024
Quality of Life in Head and Neck Cancer Patients – A Prospective Longitudinal Study (FEMH 110183-E)
Yu-Hsuan Chuang et al. | Abstract 1499 | ESTRO | 2024
Initial Clinical and Dosimetric Outcomes with TBI Planned on Helical TomoTherapy
Varghese Antony et al. | Abstract 2797 | ESTRO | 2024
Clinical Outcome and Dosimetric Feasibility of Hippocampal Sparing Whole Brain Radiotherapy
Bhuvana J et al. | Abstract 1546 | ESTRO | 2024
Moderate Hypofractionation with Simultaneous Integrated Boost after Conservative Surgery for Breast Cancer
Roberta Tummineri et al. | Abstract 2485 | ESTRO | 2024
Left Breast Cancer Dosimetry with Accuray VOLO Ultra Optimizer: A Comparison with DIBH
Patrizia Urso et al. | Abstract 1363 | ESTRO | 2024
Efficacy of frameless stereotactic radiotherapy for the treatment of presumptive canine intracranial gliomas: A retrospective analysis (2014-2017)
Moirano SJ, Dewey CW, Haney S, Yang J | Vet Comp Oncol | 2020
CyberKnife stereotactic radiotherapy for treatment of primary intracranial tumors in dogs
Carter GL, Ogilvie GK, Mohammadian LA, Bergman PJ, Lee RP, Proulx DR | J Vet Intern Med | 2021
A survey of stereotactic radiation therapy in veterinary medicine
Dunfield EM, Turek MM, Buhr KA, Christensen NI | Vet Radiol Ultrasound | 2018
Low Incidence of High-grade Lymphopenia Following Multi-course Radiotherapy for Oligometastatic Prostate Cancer
Samuel Moffet et al. | Abstract 713 | ESTRO | 2024
MRI-based Robotic SBRT Microboost with Nodal Irradiation in Treatment of Aggressive Prostate Cancer
Jonathan W. Lischalk et al. | Abstract 2015 | ESTRO | 2024
Treatment Outcomes of SABR on Oligometastases from Rare Primary Cancers
Rupinder Talwar et al. | Abstract 2987 | ESTRO | 2024
Clinical Outcomes Following Stereotactic Ablative Body Radiotherapy to Central Lung Tumours
Julie Duong et al. | Abstract 3080 | ESTRO | 2024
Stereotactic Partial Breast Irradiation: 4-year Clinical Results and Cosmetic Outcomes
Norbert Meszaro et al. | Abstract 727 | ESTRO | 2024